DK152385D0 - Fremgangsmaade til selektiv methylering af erythromycin-a derivater - Google Patents

Fremgangsmaade til selektiv methylering af erythromycin-a derivater

Info

Publication number
DK152385D0
DK152385D0 DK152385A DK152385A DK152385D0 DK 152385 D0 DK152385 D0 DK 152385D0 DK 152385 A DK152385 A DK 152385A DK 152385 A DK152385 A DK 152385A DK 152385 D0 DK152385 D0 DK 152385D0
Authority
DK
Denmark
Prior art keywords
erythromycin
derivatives
procedure
selective methylation
methylation
Prior art date
Application number
DK152385A
Other languages
English (en)
Other versions
DK152385A (da
DK172481B1 (da
Inventor
Yoshiaki Watanabe
Shigeo Morimoto
Masami Goi
Takashi Adachi
Jozi Nakagami
Morihiro Mitsukuchi
Toshifumi Asaka
Tadashi Eguchi
Kaoru Sota
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13375748&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK152385(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of DK152385D0 publication Critical patent/DK152385D0/da
Publication of DK152385A publication Critical patent/DK152385A/da
Application granted granted Critical
Publication of DK172481B1 publication Critical patent/DK172481B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198501523A 1984-04-06 1985-04-03 Fremgangsmåde til selektiv methylering af erythromycin A-derivater DK172481B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6850984 1984-04-06
JP59068509A JPS60214796A (ja) 1984-04-06 1984-04-06 6−0−メチルエリスロマイシン類の製法

Publications (3)

Publication Number Publication Date
DK152385D0 true DK152385D0 (da) 1985-04-03
DK152385A DK152385A (da) 1985-10-07
DK172481B1 DK172481B1 (da) 1998-11-23

Family

ID=13375748

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198501523A DK172481B1 (da) 1984-04-06 1985-04-03 Fremgangsmåde til selektiv methylering af erythromycin A-derivater

Country Status (17)

Country Link
US (1) US4672109A (da)
EP (1) EP0158467B1 (da)
JP (1) JPS60214796A (da)
KR (1) KR910007572B1 (da)
AR (1) AR240833A1 (da)
AT (1) ATE44384T1 (da)
AU (1) AU567803B2 (da)
CA (1) CA1225637A (da)
DE (1) DE3571323D1 (da)
DK (1) DK172481B1 (da)
ES (1) ES8602839A1 (da)
FI (1) FI77250C (da)
GE (1) GEP19960318B (da)
HK (1) HK99694A (da)
PT (1) PT80237B (da)
SU (1) SU1577700A3 (da)
ZA (1) ZA852349B (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
GB8506380D0 (en) * 1985-03-12 1985-04-11 Beecham Group Plc Chemical compounds
DE3668894D1 (en) 1985-03-12 1990-03-15 Beecham Group Plc Erythromycin-derivate.
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4833236A (en) * 1986-05-02 1989-05-23 Taisho Pharmaceutical Co., Ltd. Erythromycin derivatives
EP0260938B1 (en) * 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5756473A (en) * 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5719272A (en) * 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5808017A (en) * 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
DK0915899T3 (da) 1996-07-29 2004-11-29 Abbott Lab Fremstilling af krystallinsk form II af clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) * 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5929219A (en) * 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
US5852180A (en) * 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
IL135792A0 (en) * 1997-12-01 2001-05-20 Abbott Lab 6-o-alkyl derivatives of erythronolide b
US5932710A (en) * 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
IL124084A0 (en) * 1998-04-14 1999-04-11 Chemagis Ltd Erythromycin a derivatives and methods for the preparation thereof
IL125372A0 (en) * 1998-07-15 1999-03-12 Chemagis Ltd Erythromycin derivatives and methods for the preparation thereof
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
SI20150A (sl) * 1999-02-19 2000-08-31 Lek, Tovarna Farmacevtskih In Direktno stisljivi matriks za nadzorovano sproščanje celodnevne doze klaritromicina
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
US6627743B1 (en) 1999-12-03 2003-09-30 Abbott Laboratories 6-O-methylerythromycin A crystal form III
IL150227A0 (en) * 1999-12-16 2002-12-01 Teva Pharma Processes for preparing clarithromycin polymorphs and novel polymorph iv
AU2261901A (en) 2000-01-11 2001-07-24 Teva Pharma Processes for preparing clarithromycin polymorphs
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
EP1313486A1 (en) 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
BR0109194A (pt) * 2000-03-15 2003-02-11 Hanmi Pharm Ind Co Ltd Método para preparar claritromicina em cristais da forma ii
BR0110925A (pt) * 2000-05-15 2003-07-22 Ranbaxy Lab Ltd Processo de baixo custo para metilação seletiva de derivados da eritromicina a
ATE306491T1 (de) 2000-08-23 2005-10-15 Wockhardt Ltd Verfahren zur herstellung von wasserfreiem azithromycin
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
EP1492507A2 (en) * 2002-04-03 2005-01-05 Ranbaxy Laboratories, Ltd. Clarithromycin formulations having improved bioavailability
US6843854B2 (en) 2002-05-31 2005-01-18 Purdue Research Foundation Method and apparatus for separating a component from a mixture
ES2221807B1 (es) * 2003-06-24 2005-12-16 Ercros Industrial, S.A. Un procedimiento para la obtencion de claritromicina.
US8313776B2 (en) 2003-07-21 2012-11-20 Shionogi Inc. Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
JP2006528190A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535177A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8124744B2 (en) 2006-05-01 2012-02-28 Taisho Pharmaceutical Co., Ltd. Macrolide derivatives
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1100504A (en) * 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
US4166901A (en) * 1978-01-03 1979-09-04 Pfizer Inc. 4"-Deoxy-4"-arylglyoxamido- and aroylthioformamido derivatives of oleandomycin and its esters
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5896095A (ja) * 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd 11−o−アルキルエリスロマイシンa誘導体
JPS5896097A (ja) * 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンb誘導体
JPS5896098A (ja) * 1981-12-03 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンa誘導体
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
IL75908A0 (en) * 1984-08-31 1985-12-31 Abbott Lab Macrolide alkylation process

Also Published As

Publication number Publication date
GEP19960318B (en) 1996-06-24
EP0158467A2 (en) 1985-10-16
CA1225637A (en) 1987-08-18
JPH053475B2 (da) 1993-01-14
AU4037885A (en) 1985-10-10
AU567803B2 (en) 1987-12-03
DE3571323D1 (en) 1989-08-10
FI77250C (fi) 1989-02-10
HK99694A (en) 1994-09-23
FI851376L (fi) 1985-10-07
DK152385A (da) 1985-10-07
PT80237A (en) 1985-05-01
AR240833A1 (es) 1991-02-28
SU1577700A3 (ru) 1990-07-07
KR850007434A (ko) 1985-12-04
EP0158467A3 (en) 1986-03-19
DK172481B1 (da) 1998-11-23
ZA852349B (en) 1985-11-27
JPS60214796A (ja) 1985-10-28
PT80237B (pt) 1987-06-17
ES541898A0 (es) 1985-12-01
KR910007572B1 (ko) 1991-09-28
ES8602839A1 (es) 1985-12-01
EP0158467B1 (en) 1989-07-05
FI851376A0 (fi) 1985-04-04
US4672109A (en) 1987-06-09
ATE44384T1 (de) 1989-07-15
FI77250B (fi) 1988-10-31

Similar Documents

Publication Publication Date Title
DK152385A (da) Fremgangsmaade til selektiv methylering af erythromycin-a derivater
DK121586A (da) Fremgangsmaade til selektiv methylering af erythromycinderivater
DK76286D0 (da) Derivater af humant alfa1-antitrypsin og fremgangsmaade til fremstilling deraf
DK343682A (da) Fremgangsmaade til fremstilling af thiazolidinylalkylen-piperazin-derivater
DK155984D0 (da) Fremgangsmade til fremstilling af thiadiazolderivater
DK165984C (da) Fremgangsmaade til fremstilling af sphingosinderivater
DK350883D0 (da) Fremgangsmade til fremstilling af mycaminosyltylonolid og beslaegtede macrolidderivater og mellemprodukter herved
DK312584D0 (da) Fremgangsmaade til fremstilling af quinonderivater
DK140584D0 (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK454085A (da) Monotertiaeralkylderivater af toluendiamin
DK531085D0 (da) Fremgangsmaade til fremstilling af hydroquinonderivater
DK516286D0 (da) Fremgangsmaade til fremstilling af oxazolderivater
DK38493A (da) Fremgangsmaade til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
DK343782A (da) Fremgangsmaade til fremstilling af spirothiazolidinyl-piperazin-derivater
DK343386A (da) Fremgangsmaade til fremstilling af 2-cyanamino-pyrimidin-derivater
DK44985A (da) Apparat til afskaering af stykker af forudbestemt laengde
DK382886D0 (da) Fremgangsmaade til fremstilling af hormonfaktorderivater
DK158224C (da) Fremgangsmaade til fremstilling af indolderivater
DK270585D0 (da) Fremgangsmaade til fremstilling af aminderivater
DK450285D0 (da) Fremgangsmaade til fremstilling af pyrazolonderivater
DK493384D0 (da) Fremgangsmaade til fremstilling af bis-dioxopiperazin-derivater
DK291785A (da) Fremgangsmaade til fremstilling af iminderivater
DK75985D0 (da) Fremgangsmaade til fremstilling af et ethendiaminderivat
DK64085D0 (da) Fremgangsmaade til fremstilling af imidazolderivater
DK348886D0 (da) Fremgangsmaade til fremstilling af benzenderivater

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired